title: Antineoplasic activity of Agaricus brasiliensis basidiocarps on different maturation phases.
abstract: The fungus Agaricus brasiliensis is a Basidiomycete studied because of its immunomodulation and/or antitumor substances. The objective of this study was to verify the Agaricus brasiliensis antineoplasic activity in vivo on different basidiocarp maturation phases on Sarcoma 180 cells implanted in mice. Sarcoma cells were implanted in mice and after seven days mice were divided in three groups. The first group was treated with saline solution, the second group was treated with closed basidiocarp extract solution and the third group was treated with opened basidiocarp extract solution. After 30 days of being daily orally treated with these three solutions all animals suffered euthanasia, and the splenic index, tumor mass and volume were determined. No significant differences of the tumor growth inhibition in function of the different basidiocarp maturation phases for the Agaricus brasiliensis strain were observed. The in vivo basidiocarp antineoplasic average activity was 89.22%.
authors.affiliation: Universidade Paranaense, Programa de Mestrado em Biotecnologia Aplicada à Agricultura , Umuarama, PR , Brasil.
authors.forename: Francielly
authors.initials: F
authors.lastname: Mourão
authors.forename: Giani Andrea
authors.initials: GA
authors.lastname: Linde
authors.forename: Valdeci
authors.initials: V
authors.lastname: Messa
authors.forename: Paulo Luiz
authors.initials: PL
authors.lastname: da Cunha Júnior
authors.forename: Aristeu Vieira
authors.initials: AV
authors.lastname: da Silva
authors.forename: Augusto Ferreira
authors.initials: AF
authors.lastname: da Eira
authors.forename: Nelson Barros
authors.initials: NB
authors.lastname: Colauto
keywords: Agaricus blazei; active principle; antitumor; basidiome; fungus extract
references.citation: Evid Based Complement Alternat Med. 2008 Mar;5(1):3-15
references.pmid: 18317543
references.citation: Food Chem Toxicol. 2003 Nov;41(11):1543-50
references.pmid: 12963007
references.citation: Life Sci. 1995;57(3):269-81
references.pmid: 7596231
references.citation: Immunity. 2003 Sep;19(3):311-5
references.pmid: 14499107
references.citation: Biochemistry. 2003 May 27;42(20):6264-74
references.pmid: 12755631
references.citation: J Clin Microbiol. 1980 Jun;11(6):562-8
references.pmid: 7000807
references.citation: Biol Pharm Bull. 2001 Jul;24(7):820-8
references.pmid: 11456124
references.citation: J Ethnopharmacol. 2000 Oct;72(3):475-81
references.pmid: 10996289
references.citation: Exp Anim. 2003 Oct;52(5):371-5
references.pmid: 14625400
references.citation: Mutat Res. 2001 Sep 20;496(1-2):5-13
references.pmid: 11551475
references.citation: Biotechnol Lett. 2005 Sep;27(17):1295-9
references.pmid: 16215828
references.citation: Oncol Rep. 2004 Sep;12(3):659-62
references.pmid: 15289852
references.citation: Carcinogenesis. 1997 Aug;18(8):1603-8
references.pmid: 9276636
references.citation: Z Naturforsch C J Biosci. 2003 Jan-Feb;58(1-2):62-4
references.pmid: 12622228
references.citation: Mycologia. 2005 Jan-Feb;97(1):12-24
references.pmid: 16389952
references.citation: Biosci Biotechnol Biochem. 2005 Dec;69(12):2466-9
references.pmid: 16377912
references.citation: Evid Based Complement Alternat Med. 2008 Jun;5(2):205-19
references.pmid: 18604247
references.citation: Biol Pharm Bull. 2004 Mar;27(3):404-6
references.pmid: 14993810